Cortechs.ai | Longitudinal Assessment of Traumatic Brain Injury Using NeuroQuant®
RSNA 2025
Contact
RSNA 2026
  • Home
  • /
  • Resources
  • /
  • Longitudinal Assessment of Traumatic Brain Injury Using NeuroQuant®

Longitudinal Assessment of Traumatic Brain Injury Using NeuroQuant®

  • Category: Case studies
  • Product: NeuroQuant
  • Disease: Traumatic brain injury

A 71-year-old female presented with a history of repeated head trauma, the most recent of which occurred after hitting her head on a kitchen cabinet.

She underwent imaging to assess the extent of injury, and longitudinal follow-up was conducted using quantitative MRI with NeuroQuant® analysis.

Click here to read the case study
  • Topic: Case studies

More Resources

Cortechs.ai | Longitudinal Assessment of Traumatic Brain Injury Using NeuroQuant®
  • 3 mins

09/18/2026

What a Head CT Can and Can’t Tell You About a Concussion

For Concussion Awareness Day, learn how quantitative CT analysis can help measure subtle structural changes and support follow-up after traumatic brain injury.

Prostate Cancer Awareness Month
  • 4 mins

09/09/2026

Prostate Cancer Awareness Month: Finding the Cancer That Matters

How quantitative MRI can bring greater clarity to decisions across the prostate cancer journey.

Cortechs.ai | Longitudinal Assessment of Traumatic Brain Injury Using NeuroQuant®
  • 3 mins

09/01/2026

Quantifying What Matters: Advancing Alzheimer’s Imaging with NeuroQuant®

Explore how quantitative imaging is transforming Alzheimer’s care, from structural volumetrics and amyloid PET to treatment monitoring with NeuroQuant®.

Cortechs.ai | Longitudinal Assessment of Traumatic Brain Injury Using NeuroQuant®
  • 3 mins

08/19/2026

Brain Metastases Imaging Insights from SNO/ASCO 2026

Explore key insights from SNO/ASCO 2026 on brain metastases imaging, including lesion tracking, volumetric analysis, SRS workflows, and automated segmentation.

Cortechs.ai | Longitudinal Assessment of Traumatic Brain Injury Using NeuroQuant®
  • 2 mins

08/18/2026

Cortechs.ai Announces FDA Clearance for NeuroQuant® PET: Advancing Molecular Imaging for Cognitive Impairment

NeuroQuant® PET receives FDA 510(k) clearance, advancing quantitative PET imaging for cognitive impairment.

,

Cortechs.ai | Longitudinal Assessment of Traumatic Brain Injury Using NeuroQuant®
  • 3 mins

08/04/2026

Cortechs.ai Expands European CE Marking Across AI Imaging Platform, Accelerating Global Growth

Cortechs.ai expands EU CE Marking for the latest NeuroQuant®, NeuroQuant® Brain Tumor, and OnQ™ Prostate, advancing global AI imaging innovation

,

View our insights
Scroll to Top